168 related articles for article (PubMed ID: 17942351)
1. Effects of unfractionated and fractionated heparins on myeloperoxidase activity and interactions with endothelial cells: possible effects on the pathophysiology of equine laminitis.
de la Rebière G; Franck T; Deby-Dupont G; Salciccia A; Grulke S; Péters F; Serteyn D
Vet J; 2008 Oct; 178(1):62-9. PubMed ID: 17942351
[TBL] [Abstract][Full Text] [Related]
2. Endothelial capillary tube formation and cell proliferation induced by tumor cells are affected by low molecular weight heparins and unfractionated heparin.
Marchetti M; Vignoli A; Russo L; Balducci D; Pagnoncelli M; Barbui T; Falanga A
Thromb Res; 2008; 121(5):637-45. PubMed ID: 17692905
[TBL] [Abstract][Full Text] [Related]
3. Differential effect of the low-molecular-weight heparin, dalteparin, and unfractionated heparin on microvascular endothelial cell hemostatic properties.
Vignoli A; Marchetti M; Balducci D; Barbui T; Falanga A
Haematologica; 2006 Feb; 91(2):207-14. PubMed ID: 16461305
[TBL] [Abstract][Full Text] [Related]
4. Heparins increase endothelial nitric oxide bioavailability by liberating vessel-immobilized myeloperoxidase.
Baldus S; Rudolph V; Roiss M; Ito WD; Rudolph TK; Eiserich JP; Sydow K; Lau D; Szöcs K; Klinke A; Kubala L; Berglund L; Schrepfer S; Deuse T; Haddad M; Risius T; Klemm H; Reichenspurner HC; Meinertz T; Heitzer T
Circulation; 2006 Apr; 113(15):1871-8. PubMed ID: 16606792
[TBL] [Abstract][Full Text] [Related]
5. Heparin inhibition of endothelial cell proliferation and organization is dependent on molecular weight.
Khorana AA; Sahni A; Altland OD; Francis CW
Arterioscler Thromb Vasc Biol; 2003 Nov; 23(11):2110-5. PubMed ID: 12920044
[TBL] [Abstract][Full Text] [Related]
6. Unfractionated and low molecular weight heparin affect fibrin structure and angiogenesis in vitro.
Collen A; Smorenburg SM; Peters E; Lupu F; Koolwijk P; Van Noorden C; van Hinsbergh VW
Cancer Res; 2000 Nov; 60(21):6196-200. PubMed ID: 11085545
[TBL] [Abstract][Full Text] [Related]
7. [Influence of unfractionated and low-molecular-weight heparin on bone healing: an animal model].
Kock HJ; Werther S; Uhlenkott H; Taeger G
Unfallchirurg; 2002 Sep; 105(9):791-6. PubMed ID: 12232738
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of low-molecular-weight heparin for the prevention of equine laminitis after colic surgery.
de la Rebière de Pouyade G; Grulke S; Detilleux J; Salciccia A; Verwilghen DR; Caudron I; Gangl M; Serteyn DD
J Vet Emerg Crit Care (San Antonio); 2009 Feb; 19(1):113-9. PubMed ID: 19691592
[TBL] [Abstract][Full Text] [Related]
9. Activation of equine neutrophils by phorbol myristate acetate or N-formyl-methionyl-leucyl-phenylalanine induces a different response in reactive oxygen species production and release of active myeloperoxidase.
Franck T; Kohnen S; de la Rebière G; Deby-Dupont G; Deby C; Niesten A; Serteyn D
Vet Immunol Immunopathol; 2009 Aug; 130(3-4):243-50. PubMed ID: 19328559
[TBL] [Abstract][Full Text] [Related]
10. Neutrophil myeloperoxidase measurements in plasma, laminar tissue, and skin of horses given black walnut extract.
Riggs LM; Franck T; Moore JN; Krunkosky TM; Hurley DJ; Peroni JF; de la Rebière G; Serteyn DA
Am J Vet Res; 2007 Jan; 68(1):81-6. PubMed ID: 17199423
[TBL] [Abstract][Full Text] [Related]
11. Low-molecular-weight heparins and angiogenesis.
Norrby K
APMIS; 2006 Feb; 114(2):79-102. PubMed ID: 16519745
[TBL] [Abstract][Full Text] [Related]
12. Concentration-dependent roles for heparin in modifying lipopolysaccharide-induced activation of mononuclear cells in whole blood.
Hochart H; Jenkins PV; Preston RJ; Smith OP; White B; O'Donnell J
Thromb Haemost; 2008 Mar; 99(3):570-5. PubMed ID: 18327406
[TBL] [Abstract][Full Text] [Related]
13. The role of activated neutrophils in the early stage of equine laminitis.
de la Rebière de Pouyade G; Serteyn D
Vet J; 2011 Jul; 189(1):27-33. PubMed ID: 20655252
[TBL] [Abstract][Full Text] [Related]
14. Neutrophil extracellular traps and active myeloperoxidase concentrate in lamellar tissue of equids with naturally occurring laminitis.
Storms N; de la Rebière G; Franck T; Mouithys Mickalad A; Sandersen C; Ceusters J; Serteyn D
Vet Immunol Immunopathol; 2024 Apr; 270():110738. PubMed ID: 38452577
[TBL] [Abstract][Full Text] [Related]
15. Influence of selected heparins on human neutrophil functions in vitro.
Labrouche S; Freyburger G; Belloc F; Boisseau MR
Thromb Haemost; 1992 Nov; 68(5):556-62. PubMed ID: 1280863
[TBL] [Abstract][Full Text] [Related]
16. Intravenous low-molecular-weight heparins compared with unfractionated heparin in percutaneous coronary intervention: quantitative review of randomized trials.
Dumaine R; Borentain M; Bertel O; Bode C; Gallo R; White HD; Collet JP; Steinhubl SR; Montalescot G
Arch Intern Med; 2007 Dec; 167(22):2423-30. PubMed ID: 18071163
[TBL] [Abstract][Full Text] [Related]
17. Myeloperoxidase as a marker of hemodialysis biocompatibility and oxidative stress: the underestimated modifying effects of heparin.
Borawski J
Am J Kidney Dis; 2006 Jan; 47(1):37-41. PubMed ID: 16377383
[TBL] [Abstract][Full Text] [Related]
18. [From heparin to heparins: toward new therapeutic perspectives?].
Molho P; Tobelem G
Biomed Pharmacother; 1987; 41(4):171-5. PubMed ID: 3620582
[TBL] [Abstract][Full Text] [Related]
19. [Anticoagulant activity of low-molecular-weight heparins obtained using a hydrolase complex].
Drozd NN; Tolstenkov AS; Bannikova GE; Miftakhova NT; Lapikova ES; Makarov VA; Varlamov VP
Eksp Klin Farmakol; 2007; 70(6):19-24. PubMed ID: 18318190
[TBL] [Abstract][Full Text] [Related]
20. Depolymerization of synovial fluid hyaluronic acid (HA) by the complete myeloperoxidase (MPO) system may involve the formation of a HA-MPO ionic complex.
Green SP; Baker MS; Lowther DA
J Rheumatol; 1990 Dec; 17(12):1670-5. PubMed ID: 1964699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
